Cargando…
Immunomodulatory and Anti-inflammatory Activity in Vitro and in Vivo of a Novel Antimicrobial Candidate
The synthetic antimicrobial peptide SET-M33 has strong activity against bacterial infections caused by Gram-negative bacteria. It is currently in preclinical development as a new drug to treat lung infections caused by Gram-negative bacteria. Here we report its strong anti-inflammatory activity in t...
Autores principales: | Brunetti, Jlenia, Roscia, Giulia, Lampronti, Ilaria, Gambari, Roberto, Quercini, Leila, Falciani, Chiara, Bracci, Luisa, Pini, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207269/ https://www.ncbi.nlm.nih.gov/pubmed/27758868 http://dx.doi.org/10.1074/jbc.M116.750257 |
Ejemplares similares
-
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate
por: Brunetti, Jlenia, et al.
Publicado: (2016) -
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation
por: Cresti, Laura, et al.
Publicado: (2023) -
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs
por: Cresti, Laura, et al.
Publicado: (2022) -
A Novel Phage-Library-Selected Peptide Inhibits Human TNF-α Binding to Its Receptors
por: Brunetti, Jlenia, et al.
Publicado: (2014) -
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: Antibacterial Activity and Toxicity In Vitro and In Vivo
por: Cresti, Laura, et al.
Publicado: (2022)